Your browser doesn't support javascript.
loading
TOXICITY AND EFFICACY OF INTRAVITREAL MELPHALAN FOR RETINOBLASTOMA: 25 µg Versus 30 µg.
Liao, Albert; Hsieh, Terry; Francis, Jasmine H; Lavery, Jessica A; Mauguen, Audrey; Brodie, Scott E; Abramson, David H.
Afiliação
  • Liao A; Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Hsieh T; Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia.
  • Francis JH; Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Lavery JA; Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Mauguen A; Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Brodie SE; Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York.
  • Abramson DH; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; and.
Retina ; 41(1): 208-212, 2021 Jan 01.
Article em En | MEDLINE | ID: mdl-32106160

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Corpo Vítreo / Neoplasias da Retina / Melfalan Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Corpo Vítreo / Neoplasias da Retina / Melfalan Idioma: En Ano de publicação: 2021 Tipo de documento: Article